WallStreetZenWallStreetZen

NASDAQ: SRRK
Scholar Rock Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SRRK

Based on 2 analysts offering 12 month price targets for Scholar Rock Holding Corp

Min Forecast
$45.00+40.85%
Avg Forecast
$47.50+48.67%
Max Forecast
$50.00+56.49%

Should I buy or sell SRRK stock?

Based on 2 analysts offering ratings for Scholar Rock Holding Corp.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SRRK's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SRRK as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their SRRK stock forecasts and price targets.

SRRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-17
lockedlocked$00.00+00.00%2025-08-21

1 of 1

Forecast return on equity

Is SRRK forecast to generate an efficient return?

Company
-11.74%
Industry
130.14%
Market
-52.51%
SRRK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SRRK forecast to generate an efficient return on assets?

Company
-8.06%
Industry
47.48%
SRRK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SRRK earnings per share forecast

What is SRRK's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$3.31
Avg 2 year Forecast
-$2.30
Avg 3 year Forecast
-$1.42

SRRK revenue forecast

What is SRRK's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$4.1M
Avg 2 year Forecast
$128.4M
Avg 3 year Forecast
$331.7M

SRRK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SRRK$31.95$47.50+48.67%Strong Buy
TLX$9.38$21.00+123.88%Buy
CRNX$34.20$75.67+121.25%Strong Buy
CNTA$21.85$32.00+46.45%Strong Buy
APLS$23.13$32.86+42.05%Buy
View Top Biotech Stocks

Scholar Rock Holding Stock Forecast FAQ

Is Scholar Rock Holding Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SRRK) stock is to Strong Buy SRRK stock.

Out of 2 analysts, 2 (100%) are recommending SRRK as a Strong Buy, 0 (0%) are recommending SRRK as a Buy, 0 (0%) are recommending SRRK as a Hold, 0 (0%) are recommending SRRK as a Sell, and 0 (0%) are recommending SRRK as a Strong Sell.

If you're new to stock investing, here's how to buy Scholar Rock Holding stock.

What is SRRK's earnings growth forecast for 2025-2027?

(NASDAQ: SRRK) Scholar Rock Holding's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.2%.

Scholar Rock Holding's earnings in 2025 is -$315,687,000.On average, 9 Wall Street analysts forecast SRRK's earnings for 2025 to be -$318,392,727, with the lowest SRRK earnings forecast at -$352,787,063, and the highest SRRK earnings forecast at -$285,497,977. On average, 9 Wall Street analysts forecast SRRK's earnings for 2026 to be -$221,092,710, with the lowest SRRK earnings forecast at -$330,677,792, and the highest SRRK earnings forecast at -$10,573,999.

In 2027, SRRK is forecast to generate -$136,779,485 in earnings, with the lowest earnings forecast at -$254,737,252 and the highest earnings forecast at -$24,993,089.

What is SRRK's revenue growth forecast for 2025-2027?

(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.

Scholar Rock Holding's revenue in 2025 is $0.On average, 7 Wall Street analysts forecast SRRK's revenue for 2025 to be $393,833,405, with the lowest SRRK revenue forecast at $155,726,169, and the highest SRRK revenue forecast at $576,763,590. On average, 7 Wall Street analysts forecast SRRK's revenue for 2026 to be $12,341,202,790, with the lowest SRRK revenue forecast at $8,497,650,226, and the highest SRRK revenue forecast at $19,497,493,160.

In 2027, SRRK is forecast to generate $31,882,914,492 in revenue, with the lowest revenue forecast at $22,186,172,762 and the highest revenue forecast at $42,588,223,486.

What is SRRK's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SRRK) forecast ROA is -8.06%, which is lower than the forecast US Biotechnology industry average of 47.48%.

What is SRRK's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SRRK price target, the average SRRK price target is $47.50, with the highest SRRK stock price forecast at $50.00 and the lowest SRRK stock price forecast at $45.00.

On average, Wall Street analysts predict that Scholar Rock Holding's share price could reach $47.50 by Sep 17, 2026. The average Scholar Rock Holding stock price prediction forecasts a potential upside of 48.67% from the current SRRK share price of $31.95.

What is SRRK's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SRRK) Scholar Rock Holding's current Earnings Per Share (EPS) is -$2.92. On average, analysts forecast that SRRK's EPS will be -$3.31 for 2025, with the lowest EPS forecast at -$3.67, and the highest EPS forecast at -$2.97. On average, analysts forecast that SRRK's EPS will be -$2.30 for 2026, with the lowest EPS forecast at -$3.44, and the highest EPS forecast at -$0.11. In 2027, SRRK's EPS is forecast to hit -$1.42 (min: -$2.65, max: -$0.26).

What is SRRK's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SRRK) forecast ROE is -11.74%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.